Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Sell
22,118
-4,095
-16% -$518K ﹤0.01% 1083
2026
Q1
$2.82M Buy
26,213
+5,358
+26% +$603K ﹤0.01% 1052
2025
Q4
$2.35M Sell
20,855
-160,534
-89% -$15.3M ﹤0.01% 1136
2025
Q3
$15.7M Sell
181,389
-57,890
-24% -$5.32M 0.01% 778
2025
Q2
$24.8M Buy
239,279
+11,989
+5% +$1.12M 0.01% 666
2025
Q1
$19.8M Buy
227,290
+111,872
+97% +$14.9M 0.01% 709
2024
Q4
$18.2M Sell
115,418
-5,199
-4% -$716K 0.01% 738
2024
Q3
$15.6M Sell
120,617
-55,633
-32% -$6.92M 0.01% 761
2024
Q2
$21M Buy
176,250
+102,553
+139% +$10.9M 0.01% 695
2024
Q1
$7.01M Buy
73,697
+67,157
+1,027% +$6M ﹤0.01% 902
2023
Q4
$566K Buy
6,540
+365
+6% +$24.9K ﹤0.01% 1413
2023
Q3
$405K Buy
6,175
+110
+2% +$8.21K ﹤0.01% 1443
2023
Q2
$423K Sell
6,065
-668
-10% -$38.4K ﹤0.01% 1421
2023
Q1
$324K Buy
+6,733
New +$327K ﹤0.01% 1448

Other funds holding GKOS

Amundi's GKOS Position: Q2 2026 in Review

Amundi reduced its Glaukos (GKOS) stake by 16% in Q2 2026, selling an estimated $518K and leaving 22,118 shares worth $3.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

Amundi first reported a position in GKOS in Q1 2023 and has held it in 14 quarters since. The position peaked at $24.8M in Q2 2025. 365 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Amundi held 22,118 shares of Glaukos worth $3.09M as of Q2 2026.
  • Amundi sold 4,095 Glaukos shares in Q2 2026, an estimated $518K.
  • Glaukos made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1083 holding.
  • Amundi first reported a position in Glaukos in Q1 2023 and has held it in 14 quarters since.
  • Amundi's Glaukos position peaked at $24.8M in Q2 2025.
  • 365 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.